85 studies found for:    Open Studies | "Hypercholesterolemia"
Show Display Options
Rank Status Study
21 Recruiting Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis Therapy
Condition: Heterozygous Familial Hypercholesterolemia
Interventions: Drug: Alirocumab;   Drug: Placebo
22 Unknown  Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia
Condition: Hypercholesterolemia
Intervention: Other: Food supplement
23 Unknown  Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
Conditions: Hypercholesterolemia;   HIV Infections
Interventions: Drug: Ezetimibe;   Drug: Rosuvastatin (standard care)
24 Unknown  Soy Food Intervention Trial
Condition: Familial Hypercholesterolemia
Interventions: Dietary Supplement: soy protein diet;   Dietary Supplement: rapeseed oil
25 Not yet recruiting A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients
Condition: Hypercholesterolemia
Intervention: Drug: DW-3102
26 Recruiting The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
Condition: Hypercholesterolemia
Intervention: Drug: Rosuvastatin/Ezetimibe
27 Recruiting To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
Condition: Severe Hypercholesterolemia
Intervention: Drug: Atorvastatin, Probucol, Cilostazol
28 Unknown  Effect of Rapeseed Oil and Sunflower Oil
Condition: Familial Hypercholesterolemia
Interventions: Dietary Supplement: rapeseed oil;   Dietary Supplement: sunflower oil
29 Unknown  Effect of Omega-3 Fatty Acid on Endothelial Function
Condition: Familial Hypercholesterolemia
Interventions: Drug: Omega-3;   Drug: placebo
30 Recruiting Study to Evaluate the Effects of MBX-8025 in Patients With HoFH
Condition: Homozygous Familial Hypercholesterolemia
Interventions: Other: Run-In Period: Placebo;   Drug: MBX-8025 50 mg (Dose Escalation Period 1);   Drug: MBX-8025 50 mg or 100 mg (Dose Escalation Period 2);   Drug: MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3)
31 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Anesthesia;   Pain;   Reflux;   Nausea;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma
Intervention: Drug: Ampicillin
32 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
33 Not yet recruiting Trial Assessing Efficacy, Safety and Tolerability of PCSK9 Inhibition in Paediatric Subjects With Genetic LDL Disorders
Condition: Heterozygous Familial Hypercholesterolemia
Interventions: Drug: Evolocumab;   Drug: Placebo
34 Not yet recruiting The Combined Portfolio Diet and Exercise Study
Conditions: Cardiovascular Diseases;   Hypercholesterolemia;   Type 2 Diabetes;   Metabolic Syndrome
Interventions: Behavioral: Portfolio Plus Diet;   Behavioral: DASH-like (high fiber) Diet
35 Unknown  Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia
Condition: Hypercholesterolemia
Interventions: Drug: Rosuvastatin;   Drug: Ezetimibe
36 Unknown  The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients
Condition: Hypercholesterolemia
Intervention: Other: LDL-cholesterol
37 Recruiting Genetically Guided Statin Therapy
Conditions: Hypercholesterolemia;   HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Genetic: Reporting for SLCO1B1*5 allele at randomization;   Genetic: Reporting for SLCO1B1*5 allele at the end;   Genetic: Genetic testing for SLCO1B1*5 allele
38 Recruiting Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects
Condition: Hypercholesterolemia
Interventions: Biological: AFFITOPE® AT04A+adjuvant;   Biological: AFFITOPE® AT06A+adjuvant;   Biological: Adjuvant without active component
39 Recruiting Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients
Conditions: Acute Kidney Injury;   Arterial Hypertension;   Obesity;   Cardio Vascular Disease;   Diabetes Mellitus;   Chronic Liver Disease;   Hypercholesterolemia
Interventions: Device: Nephro Check Test;   Other: serum creatinine measurement
40 Recruiting Atorvastatin Study in Cardiovascular Disease Risk
Conditions: Hypercholesterolemia;   Dyslipidemia

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years